139,09 €*

in Vorbereitung

This is a unique book focusing on the management of rare sarcomas, which pose an important challenge in Europe and in the US, as they represent nearly one quarter of all new diagnoses of cancer and have lower survival rates than common cancer. Discussing a range of tumors from clear cell and epithelioid sarcoma to solitary fibrous tumor and myxoid fibrosarcoma, this book provides invaluable expertise according to evidence-based guidelines and uses a patient-centered multi-disciplinary approach.

Each of the chapters discusses the forms of rare sarcomas both from an oncological and a pathological perspective. This book aims to help the sarcoma expert in improving the management, quality of care and outcome for patients with rare tumors, which have now been recognised as a public health priority.

The authors are experts from specialist sarcoma centers focusing on the capacity to develop clinical guidelines, and to foster clinical, translational and epidemiologicalresearch for rare cancers.




<p>Clear cell sarcoma
Epithelioid sarcoma
PEComa
Desmoplastic small round cell tumour
Malignant solitary fibrous tumour
Alveolar soft part sarcoma
Epithelioid Hemangioendothelioma
Low grade fibromyxoid sarcoma/sclerosing epithelioid fibrosarcoma
New Born and Infant Soft Tissue Sarcomas.</p><p></p>
ISBN 978-3-030-24696-9
Artikelnummer 9783030246969
Medientyp Buch
Auflage 1st ed. 2020
Copyrightjahr 2020
Verlag Springer, Berlin
Umfang VI, 164 Seiten
Abbildungen VI, 164 p. 29 illus., 24 illus. in color.
Sprache Englisch